Who owns AQST?
Institutional ownership of Aquestive Therapeutics Inc. from Form 13F, Q2 2026
185 institutional managers reported holding Aquestive Therapeutics Inc. (AQST) in Form 13F filings for Q2 2026, with 72,032,806 shares worth $300M. The largest reported holder was Bratton Capital Management, L.P. Managers that filed both quarters added a net 144,253 shares (+0.2%). 23 opened new positions and 18 sold out.
- Funds holding
- 185
- Value held
- $300M
- New / sold out
- 23 / 18
- Net shares, same filers
- +0.2%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of AQST
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Bratton Capital Management, L.P. | $40.8M | 13.6% | 9,810,958 | Unchanged |
| BlackRock, Inc. | $33.6M | 11.2% | 8,069,373 | Added |
| RTW Investments, LP | $30.9M | 10.3% | 7,426,471 | Unchanged |
| Vanguard Capital Management LLC | $19.1M | 6.4% | 4,584,533 | Added |
| Federated Hermes, Inc. | $12.9M | 4.3% | 3,112,561 | Added |
| State Street Corp | $12.2M | 4.1% | 2,928,020 | Added |
| Geode Capital Management, LLC | $10.9M | 3.6% | 2,622,888 | Added |
| Samsara Biocapital, LLC | $10.4M | 3.5% | 2,500,000 | Unchanged |
| Bank of America Corp | $6.9M | 2.3% | 1,668,423 | Trimmed |
| Sio Capital Management, LLC | $6.2M | 2.1% | 1,486,175 | Trimmed |
| Propel Bio Management, LLC | $6.0M | 2.0% | 1,442,397 | Added |
| Wasatch Advisors LP | $5.8M | 1.9% | 1,385,843 | Added |
| Two Sigma Investments, LP | $5.3M | 1.8% | 1,281,227 | Added |
| Nuveen, LLC | $5.1M | 1.7% | 1,215,225 | Added |
| Janney Montgomery Scott LLC | $4.6M | 1.5% | 1,106,160 | Added |
| Wells Fargo & Company | $4.5M | 1.5% | 1,089,037 | Added |
| Commonwealth Equity Services, LLC | $4.4M | 1.5% | 1,046,175 | Trimmed |
| Barclays PLC | $4.1M | 1.4% | 996,665 | Added |
| Blue Owl Capital Holdings LP | $3.9M | 1.3% | 942,932 | Trimmed |
| Northern Trust Corp | $3.5M | 1.2% | 831,151 | Added |
| BNP Paribas Financial Markets | $3.3M | 1.1% | 794,688 | Trimmed |
| Balyasny Asset Management L.P. | $3.1M | 1.0% | 744,536 | Trimmed |
| Vanguard Portfolio Management LLC | $3.1M | 1.0% | 734,245 | Added |
| Morgan Stanley | $2.7M | 0.9% | 658,617 | Trimmed |
| Vanguard Fiduciary Trust Co | $2.7M | 0.9% | 651,211 | Added |
Share of 13F holdings is each fund's shares as a share of the 72,032,806 AQST shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Nuveen, LLC Added+$4.0M
- Propel Bio Management, LLC Added+$3.0M
- BlackRock, Inc. Added+$2.3M
- Wasatch Advisors LP Added+$2.1M
- Renaissance Technologies LLC New+$1.7M
- State Street Corp Added+$1.6M
- Man Group plc New+$1.5M
- HRT Financial LP New+$1.4M
- DAFNA Capital Management LLC Added+$1.2M
- Marshall Wace, LLP Added+$1.1M
Biggest sellers in Q2 2026
- Balyasny Asset Management L.P. Trimmed-$9.0M
- Morgan Stanley Trimmed-$3.9M
- Bank of America Corp Trimmed-$3.1M
- Jane Street Group, LLC Trimmed-$2.5M
- Sio Capital Management, LLC Trimmed-$1.8M
- Blue Owl Capital Holdings LP Trimmed-$1.7M
- Diametric Capital, LP Sold out-$1.4M
- Walleye Capital LLC Trimmed-$1.3M
- Point72 Asset Management, L.P. Sold out-$1.2M
- Susquehanna International Group, LLP Trimmed-$870K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $31.6M and sold $31.0M; 68 added and 44 trimmed.
Questions about AQST ownership
- Who owns AQST stock?
- 185 institutional investment managers reported AQST positions in their Form 13F filings for Q2 2026, holding 72,032,806 shares worth $300M in total. Bratton Capital Management, L.P. reported the largest position.
- Are funds buying or selling AQST?
- In Q2 2026, 23 managers opened new AQST positions, 68 added, 44 trimmed and 18 sold out. Managers that filed in both quarters added a net 144,253 shares.
- How current is this AQST institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to AQST by CUSIP. Options are left out. AQST news and filings · AQST insider trades · Top funds